Market Place
Sourcing Support
Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US
10 Dec 2024 //
FDA
ScieGen`s Generic Diltiazem Hydrochloride Receives Approval in the U.S.
06 Apr 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
ScieGen`s Generic Diltiazem Hydrochloride Receives Approval in the U.S.
23 Sep 2022 //
FDA
ScieGen`s Generic Pregabalin Receives Approval in the U.S.
14 Sep 2022 //
FDA
ScieGen Pharma`s Generic Pirfenidone Receives Approval in the U.S.
01 Aug 2022 //
FDA
Sciegen Pharms` Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
ScieGen Pharma`s Generic ValsartanReceives Approval In US
30 Oct 2021 //
FDA
ScieGen Pharma`s Generic ValsartanReceives Approval In US
30 Oct 2021 //
FDA
ScieGen Pharma`s Generic Carbidopa;Levodopa Receives Approval in US
07 Oct 2021 //
FDA
Sciegen Pharms Inc`s Generic Levetiracetam Receives Tentative Approval In US
15 Jun 2021 //
FDA
Sciegen Pharms Generic Carbidopa Levodopa Receives Approval In US
12 May 2021 //
FDA
Sciegen Pharms Generic Metformin Hydrochloride Receives Approval In US
21 Apr 2021 //
FDA
Sciegen Pharms Generic Pirfenidone Receives Tentative Approval In US
18 Nov 2020 //
FDA
Sciegen Pharms Generic Naproxen Receives Approval In US
25 Feb 2020 //
FDA
ScieGen Pharmaceuticals`s Generic Naproxen Sodium Receives Approval in US
31 Oct 2019 //
FDA
FDA greenlights nine Lyrica generics
25 Jul 2019 //
IN-PHARMATECHNOLOGIST
Sciegen Pharms Generic Pregabalin Receives Approval In US
24 Jul 2019 //
FDA
Lyrica generics roll: Pfizer blockbuster finally hits patent cliff
23 Jul 2019 //
FIERCE PHARMA
FDA Approves First Lyrica Generics From 9 Sponsors
22 Jul 2019 //
RAPS
Sciegen Pharms` Generic Ranolazine Receives Approval In US
04 Jun 2019 //
Irbesartan products under recall - Updated January 18, 2019
19 Jan 2019 //
FDA
Sciegen Pharms` Generic Hydrochlorothiazide Receives Approval in US
14 Jan 2019 //
FDA
Enforcement Report - Week of December 19, 2018
19 Dec 2018 //
FDA
Walmart and Aurobindo sued as litigation mounts over contaminated blood pressure drugs
08 Dec 2018 //
FIERCE PHARMA
EMA Warns of Impurity in Valsartan From Mylan
20 Nov 2018 //
RAPS
FDA Alerts to Recalls Over Non-Valsartan Product Found to Contain Impurities
02 Nov 2018 //
RAPS
FDA warns some irbesartan tablets in U.S. contain impurity
01 Nov 2018 //
FIERCE PHARMA
Sciegen Pharmaceuticals Recalls Irbesartan Due to Trace Amounts of NDEA
31 Oct 2018 //
FDA
FDA updates on angiotensin II receptor blocker (ARB) recalls
31 Oct 2018 //
FDA
Aurobindo Pharma Recalls Irbesartan due to Trace NDEA Impurity
30 Oct 2018 //
FDA
Irbesartan products under recall - Updated October 29, 2018
01 Oct 2018 //
FDA
Sciegen Pharm’s Generic Aripiprazole Receives Approval In US
21 Apr 2018 //
FDA
Sciegen Pharm’s Generic Quetiapine Fumarate Receives Approval In US
04 Dec 2017 //
FDA
Sciegen Pharms Generic Bupropion Hydrochloride Receives Approval In US
13 Apr 2017 //
FDA
Sciegen`s Generic Omeprazole; Sodium Bicarbonate Recevies Approval In US
06 Dec 2016 //
FDA
Sciegen`s Generic Olmesartan Medoxomil Receives Tenative Approval In US
16 Nov 2016 //
FDA
Sciegen Pharms Inc ANDA Bupropion Hydrochloride Approved in US
17 Aug 2016 //
FDA
Sciegen Pharm`s Generic Gabapentin approved in US as an antiepileptic drug
04 Feb 2016 //
FDA
